de las Peņas, R <br/><br/>
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2006 
 - 668-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdj135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>DNA Repair--genetics<br/>Deoxycytidine--administration & dosage<br/>Genotype<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Polymorphism, Genetic<br/>Survival Analysis<br/>Gemcitabine